Literature DB >> 20335423

Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs.

Lance R Peterson1, Oliver Liesenfeld, Christopher W Woods, Stephen D Allen, David Pombo, Parul A Patel, Maitry S Mehta, Bradly Nicholson, DeAnna Fuller, Andrew Onderdonk.   

Abstract

The rate of methicillin-resistant Staphylococcus aureus (MRSA) infection continues to rise in many health care settings. Rapid detection of MRSA colonization followed by appropriate isolation can reduce transmission and infection. We compared the performance of the new Roche LightCycler MRSA advanced test to that of the BD GeneOhm MRSA test and culture. Double-headed swabs were used to collect anterior nasal specimens from each subject. For both tests, DNA was extracted and real-time PCR was performed according to manufacturer's instructions. For culture, one swab of the pair was plated directly to CHROMagar MRSA. The swab paired with the BD GeneOhm MRSA test was also placed into an enrichment broth and then plated to CHROMagar MRSA. Colonies resembling staphylococci were confirmed as S. aureus by standard methods. Discrepant specimens had further testing with additional attempts to grow MRSA as well as sample amplicon sequencing. Agreement between results for the two swabs was 99.3% for those with valid results. A total of 1,402 specimens were tested using direct culture detection of MRSA as the gold standard; 187 were culture positive for MRSA. The LightCycler MRSA advanced test had relative sensitivity and specificity of 95.2% (95% confidence interval [CI]: 91.1% to 97.8%) and 96.4% (95% CI: 95.2% to 97.4%), respectively. The BD GeneOhm assay had relative sensitivity and specificity of 95.7% (95% CI: 91.7% to 98.1%) and 91.7% (95% CI: 90.0% to 93.2%), respectively. Following discrepancy analysis, the relative sensitivities of the LightCycler MRSA advanced test and the BD GeneOhm MRSA assay were 92.2 and 93.2%, respectively; relative specificities were 98.9 and 94.2%, respectively. Specificity was significantly better (P<0.001) with the LightCycler MRSA advanced test. The sensitivity of direct culture was 80.4%. The LightCycler MRSA advanced test is a useful tool for sensitive and rapid detection of MRSA nasal colonization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335423      PMCID: PMC2863939          DOI: 10.1128/JCM.00003-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.

Authors:  David H Wyllie; Derrick W Crook; Tim E A Peto
Journal:  BMJ       Date:  2006-06-23

Review 2.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

3.  Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus.

Authors:  Patrice Francois; Manuela Bento; Gesuele Renzi; Stephan Harbarth; Didier Pittet; Jacques Schrenzel
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

4.  5 Million Lives Campaign. Case study: an MRSA intervention at Evanston Northwestern Healthcare.

Authors:  Lance R Peterson; Donna M Hacek; Ari Robicsek
Journal:  Jt Comm J Qual Patient Saf       Date:  2007-12

5.  Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares.

Authors:  D M Wolk; E Picton; D Johnson; T Davis; P Pancholi; C C Ginocchio; S Finegold; D F Welch; M de Boer; D Fuller; M C Solomon; B Rogers; M S Mehta; L R Peterson
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

6.  To screen or not to screen for methicillin-resistant Staphylococcus aureus.

Authors:  Lance R Peterson; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

7.  Three-year surveillance of community-acquired Staphylococcus aureus infections in children.

Authors:  Sheldon L Kaplan; Kristina G Hulten; Blanca E Gonzalez; Wendy A Hammerman; Linda Lamberth; James Versalovic; Edward O Mason
Journal:  Clin Infect Dis       Date:  2005-05-06       Impact factor: 9.079

8.  Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.

Authors:  Kevin B Laupland; Terry Ross; Daniel B Gregson
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

9.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

10.  Implementation of a universal admission surveillance and decolonization program for methicillin-resistant staphylococcus aureus (MRSA) reduces the number of MRSA and total number of S. aureus isolates reported by the clinical laboratory.

Authors:  Donna M Hacek; Suzanne M Paule; Richard B Thomson; Ari Robicsek; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

View more
  24 in total

Review 1.  Microbiome of the paranasal sinuses: Update and literature review.

Authors:  Jivianne T Lee; Daniel N Frank; Vijay Ramakrishnan
Journal:  Am J Rhinol Allergy       Date:  2016 Jan-Feb       Impact factor: 2.467

2.  Evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test for detection of MRSA nasal colonization.

Authors:  W C Yam; Gilman K H Siu; P L Ho; T K Ng; T L Que; K T Yip; Cathie P K Fok; Jonathan H K Chen; Vincent C C Cheng; K Y Yuen
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

3.  Dual-site sampling improved detection rates for MRSA colonization in patients with cutaneous abscesses.

Authors:  L May; C McCann; G Brooks; R Rothman; L Miller; J Jordan
Journal:  Diagn Microbiol Infect Dis       Date:  2014-05-20       Impact factor: 2.803

4.  Ward-specific rates of nasal cocolonization with methicillin-susceptible and -resistant Staphylococcus spp. and potential impact on molecular methicillin-resistant Staphylococcus aureus screening tests.

Authors:  Sophie Trouillet-Assant; Jean-Philippe Rasigade; Sebastien Lustig; Yannick Lhoste; Florent Valour; Claude Guerin; Frederic Aubrun; Sylvestre Tigaud; Frederic Laurent
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

5.  Multiplex real-time PCR assay for detection of methicillin-resistant Staphylococcus aureus (MRSA) strains suitable in regions of high MRSA endemicity.

Authors:  Jeong-Uk Kim; Choong-Hwan Cha; Hae-Kyong An; Ho-Jun Lee; Mi-Na Kim
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

6.  Nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction: a potential use in guiding antibiotic therapy for pneumonia.

Authors:  Jennifer A Johnson; Michael E Wright; Lyndsay A Sheperd; Daniel M Musher; Bich N Dang
Journal:  Perm J       Date:  2014-11-24

Review 7.  Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.

Authors:  Rajyasree Emmadi; Jerry B Boonyaratanakornkit; Rangaraj Selvarangan; Venkatakrishna Shyamala; Barbara L Zimmer; Laurina Williams; Bonita Bryant; Ted Schutzbank; Michele M Schoonmaker; Jean A Amos Wilson; Leslie Hall; Preeti Pancholi; Kathryn Bernard
Journal:  J Mol Diagn       Date:  2011-08-25       Impact factor: 5.568

8.  COMPARISON OF METHODS TO IDENTIFY Neisseria meningitidis IN ASYMPTOMATIC CARRIERS.

Authors:  Camila F Rizek; André Machado Luiz; Gracilene Ramos de Assis; Silvia Figueiredo Costa; Anna Sara Levin; Marta Heloisa Lopes
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

9.  Comparison of two commercial PCR methods for methicillin-resistant Staphylococcus aureus (MRSA) screening in a tertiary care hospital.

Authors:  Aylin Aydiner; Jessica Lüsebrink; Verena Schildgen; Ingo Winterfeld; Oliver Knüver; Katja Schwarz; Sabine Messler; Oliver Schildgen; Frauke Mattner
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

10.  Methicillin-resistant Staphylococcus aureus in nasal surveillance swabs at an intensive care unit: an evaluation of the LightCycler MRSA advanced test.

Authors:  Hee Jin Huh; Eu Suk Kim; Seok Lae Chae
Journal:  Ann Lab Med       Date:  2012-10-17       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.